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Abstract
Azole resistance is an emerging problem in Aspergillus which impacts the management of aspergillosis. Here in we report
the emergence and clonal spread of resistance to triazoles in environmental Aspergillus fumigatus isolates in India. A total of
44 (7%) A. fumigatus isolates from 24 environmental samples were found to be triazole resistant. The isolation rate of
resistant A. fumigatus was highest (33%) from soil of tea gardens followed by soil from flower pots of the hospital garden
(20%), soil beneath cotton trees (20%), rice paddy fields (12.3%), air samples of hospital wards (7.6%) and from soil admixed
with bird droppings (3.8%). These strains showed cross-resistance to voriconazole, posaconazole, itraconazole and to six
triazole fungicides used extensively in agriculture. Our analyses identified that all triazole-resistant strains from India shared
the same TR34/L98H mutation in the cyp51 gene. In contrast to the genetic uniformity of azole-resistant strains the azole-
susceptible isolates from patients and environments in India were genetically very diverse. All nine loci were highly
polymorphic in populations of azole-susceptible isolates from both clinical and environmental samples. Furthermore, all
Indian environmental and clinical azole resistant isolates shared the same multilocus microsatellite genotype not found in
any other analyzed samples, either from within India or from the Netherlands, France, Germany or China. Our population
genetic analyses suggest that the Indian azole-resistant A. fumigatus genotype was likely an extremely adaptive
recombinant progeny derived from a cross between an azole-resistant strain migrated from outside of India and a native
azole-susceptible strain from within India, followed by mutation and then rapid dispersal through many parts of India. Our
results are consistent with the hypothesis that exposure of A. fumigatus to azole fungicides in the environment causes cross-
resistance to medical triazoles. The study emphasises the need of continued surveillance of resistance in environmental and
clinical A. fumigatus strains.
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Introduction
Aspergillus fumigatus is the commonest etiologic agent of various
clinical forms of bronchopulmonary aspergillosis including aller-
gic, acute invasive and chronic pulmonary aspergillosis (CPA). The
disease has a global distribution and it is widespread in India [1].
Invasive aspergillosis is the most severe manifestation with an
overall annual incidence varying from 2 to 10% in the
immunosuppressed patient population whereas CPA affects
primarily immunocompetent individuals with an estimated prev-
alence of 3 million worldwide [2,3]. Azoles, such as itraconazole,
voriconazole, and posaconazole are among the recommended
first-line drugs in the treatment and prophylaxis of aspergillosis
[4,5]. Azole resistance is an emerging problem in A. fumigatus in
Europe and has been shown to be associated with increased
probability of treatment failure [6–8]. Azole resistance is
commonly due to mutations in the cyp51A gene, which encodes
14-a-demethylase in the ergosterol biosynthesis pathway. In azole-
resistant clinical A. fumigatus isolates a wide variety of mutations in
the cyp51A gene have been found, such as substitutions at codons
G54, G138, P216, F219, M220 and G448 [9–12]. However, in the
Netherlands a different resistance mechanism consisting of the
L98H substitution, together with a 34-bp tandem repeat (TR34) in
the promoter region of this gene (TR34/L98H) was found to be
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present in over 90% of azole resistant isolates [13]. The TR34/
L98H resistance mechanism has been endemic in the Netherlands
and subsequently reported from other European countries such as
Denmark, France, Germany, Spain and the United Kingdom
[12,14–19].
Isolates of A. fumigatus with TR34/L98H mutations exhibit a
pan-azole resistant phenotype and were recovered primarily from
azole-naive patients and from environmental sources in the
Netherlands and Denmark [15,17,20,21]. These observations
suggest that patients acquire azole-resistant Aspergillus from
environmental sources rather than arising through azole therapy.
The consequence of this type of resistance development is that
patients at risk can be exposed to and infected by azole-resistant
strains in the environment. Furthermore, TR34/L98H isolates
were cross-resistant to certain azole fungicides employed exten-
sively in agriculture for crop protection against phytopathogenic
molds, to prevent post-harvest spoilage [21]. An environmental
route of resistance development poses a major challenge because
multiplication and spread of resistant strains in the environment
can be anticipated. Recently, we reported from India the
occurrence of TR34/L98H mutations in the cyp51A gene in A.
fumigatus isolates from patients with chronic respiratory disease
who had not previously been exposed to azoles [22]. This
emergence of resistance in Indian clinical isolates prompted us to
undertake a wide environmental survey of azole resistant A.
fumigatus isolates in India. Herein, we report multi-triazole resistant
environmental A. fumigatus isolates from India harboring TR34/
L98H mutations in the cyp51A gene, from soil samples of paddy
fields, tea gardens, cotton trees, flower pots and indoor air of
hospital. Furthermore, we investigated the cross resistance of these
environmental and clinical TR34/L98H A. fumigatus isolates to
registered and commonly used azole fungicides in India and
determined the genetic relatedness of Indian environmental and
clinical A. fumigatus isolates harboring the TR34/L98H mutations
and compared them with isolates from Europe and China.
Results
Isolation of Environmental Strains of A. fumigatus
Of the 486 environmental samples tested, 201 (41.4%) showed
the presence of A. fumigatus in all types of substrates tested except
nursery plants soil and decayed wood inside tree trunk hollows.
The data of state-wise distribution and prevalence of azole
resistant A. fumigatus in soil and air samples is presented in
Table 1 and Figure 1. Of the 201 A. fumigatus positive samples, 630
individual A. fumigatus colonies were obtained from Sabourauds
dextrose agar (SDA) plates. The count of A. fumigatus on primary
SDA plate ranged from one colony to confluent growth. Besides A.
niger, A. flavus, A. terreus, other molds such as mucorales, and
Penicillium species were also observed in soil samples. Out of 630 A.
fumigatus colonies tested, 44 (7%) isolates originating from 24
samples grew on SDA plates containing 4 mg/L itraconazole.
Among these 44 itraconazole-resistant (ITC+) isolates, 15 were
obtained from different potted plants of the V. P. Chest Institute
(VPCI) garden, Delhi, 12 from rice paddy fields in Bihar, 9 from
tea gardens in Darjeeling, 3 each from soil beneath cotton trees
(Bombax ceiba) from Kolkata and from aerial sampling of patient
rooms of the VPCI hospital, and 2 from soil containing bird
droppings in Tamil Nadu (Table 1). Overall, 5% (24/486) of the
samples tested harbored itraconazole resistant A. fumigatus. Among
the positive samples, 11.9% (24/201) showed at least one colony of
resistant A. fumigatus. The isolation rate of itraconazole resistant A.
fumigatus was highest 33% (9/27) from the soil of tea gardens
followed by soil from flower pots of the hospital garden 20% (15/
75), soil beneath cotton trees 20% (3/15), rice paddy fields 12.3%
(12/97), air samples of hospital wards 7.6% (3/39) and from soil
admixed with bird droppings 3.8% (2/52). There was no isolation
of resistant A. fumigatus isolates from soil samples of public parks
and gardens inside the hospital premises and red chilly fields in
Tamil Nadu.
Evidence for Cross-Resistance to Triazole Antifungal
Drugs
All the 44 ITC+ A. fumigatus isolates from the environment
showed reduced susceptibility to azoles. The geometric mean
(GM) MIC of itraconazole (GM, 16 mg/L) was the highest,
followed by voriconazole (GM, 8.7 mg/L), and posaconazole
(GM, 1.03 mg/L). All the antifungal drugs tested showed reduced
efficacy against all the ITC+ A. fumigatus isolates (Table 2),
consistent with cross-resistance of these isolates to the tested azoles.
Among the triazoles, the MIC difference between wild type and
TR34/L98H isolates were the highest for itraconazole (r = 0.96)
followed by voriconazole (r = 0.91) and posaconazole (r = 0.72). Of
the10 fungicides, 7 showed dissimilarity between the MICs with
greatest differences found for bromuconazole, difenoconazole,
tebuconazole (r = 0.96 each) followed by hexaconazole (r = 0.95),
epoxiconazole (r = 0.92), metconazole (r = 0.89) and lowest for
cyproconazole (r = 0.22) (Table 2).
Evidence for Clonal Spread of a Single Triazole-Resistant
A. fumigatus Genotype
Our genotype analyses identified that all of the 44 ITC+ A.
fumigatus isolates from India exhibited the same TR34/L98H
genotype at the cyp51A gene. Furthermore, these strains had the
same allele across all nine examined microsatellite loci (Fig. 2). In
contrast to the genetic uniformity of azole-resistant strains from
India, the azole-susceptible isolates from both patients and
environments in India were genetically very diverse. Indeed, all
nine loci were highly polymorphic in populations of azole-
susceptible isolates from both clinical and environmental samples.
Origin(s) of the Azole-resistant A. fumigatus Genotype in
India
The widespread occurrence of a single azole-resistant genotype
across India contrasts with those found in several other regions
outside of India. In our analyses, a diversity of genotypes has been
found for clinical TR34/L98H azole-resistant A. fumigatus strains in
China, France, Germany and in both clinical and environmental
sources in the Netherlands (Figs. 2 and 3). To examine the origin(s)
of the azole - resistant genotype in India, we first attempted to
isolate azole - susceptible strains from the 24 soil samples that
contained the 44 azole-resistant strains. Among these 24 soil
samples, we successfully obtained and analyzed eight azole-
susceptible isolates from seven of the 24 samples through dilution
plating, single colony purification, and screening using itracona-
zole-containing and non-containing media. Our genotype analyses
using the 9 microsatellite markers revealed that none of the eight
strains had a genotype identical to the azole-resistant genotype in
India. These eight azole-susceptible strains belonged to four
different genotypes. Interestingly, three of the genotypes shared no
allele with the azole-resistant genotype at any of the nine
microsatellite loci while the remaining genotype shared an allele
with the azole-resistant genotype at only one of the nine loci.
To further explore the potential origin(s) of the azole-resistant
genotype in India, we further analyzed the genotypes of all the
azole-susceptible strains from within India. Among the nine
microsatellite loci, we were able to find allele-sharing at only six
Azole Resistant A. fumigatus from India
PLOS ONE | www.plosone.org 2 December 2012 | Volume 7 | Issue 12 | e52871
loci between the Indian azole-resistant genotype and the 35 azole-
susceptible clinical and soil/air isolates in India. The highest
number of loci with shared alleles between any of the 35 azole
susceptible strains and the resistant genotype was at only two of the
nine loci. Therefore, even with free recombination among the
genotypes represented by the 35 azole susceptible strains in India,
the azole-resistant genotype could not be generated due to the lack
of corresponding alleles at three of the nine loci (loci 2A, 3A, and
4C, Fig. 2) found only in the azole-resistant strains.
Interestingly, though not identical, several strains from outside
of India were found to have genotypes more similar to the Indian
azole-resistant strains than the Indian azole-susceptible strains
(Fig. 2). For example, ten of the 51 strains from outside of India
shared alleles in at least four of the nine loci with the Indian azole
–resistant genotype, with four of the 10 strains sharing alleles at
five loci. These 10 strains were all similarly resistant to azoles as
the Indian azole-resistant genotype and all 10 strains carried the
same TR34/L98H mutation. The combined allelic comparisons
identified that the azole-resistant strains from outside of India
Figure 1. An outline map of India showing state-wise isolation of multiple-triazole resistant Aspergillus fumigatus isolates from
variety of environmental samples.
doi:10.1371/journal.pone.0052871.g001
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contained alleles at seven of the nine microsatellite loci found in
the Indian azole-resistant genotype, one more than all the Indian
azole-susceptible strains combined. At locus 2A, only the sample
from outside India contained the allele #14 (in 8 of the 51 strains)
found in the Indian azole-resistant genotype while the azole-
susceptible sample from India did not contain this allele (Fig. 2).
However, a reverse situation occurred at locus 2C where allele #9
in the Indian azole-resistant genotype was found in the Indian
azole-susceptible population (in one of the 35 strains) but not from
outside of India. Finally, different from the other eight loci, locus
4C had a unique allele (#28) found only in the Indian azole-
resistant strains and this allele was absent from any other strains in
the whole analyzed sample, either from within or outside of India
(Fig. 2).
Discussion
The site specific mode of action and intensive use of
demethylase inhibitors (DMIs) fungicides for post harvest spoilage
crop protection against phytopathogenic molds, has led to the
development of resistance in many fungi of agricultural impor-
tance. It is anticipated that the excessive use of azoles in
agriculture would not only influence the plant pathogenic fungi
but also would inevitably influence susceptible species of the
saprophytic flora [23]. Many potentially human pathogenic fungi
such as Coccidioides, Histoplasma, Aspergillus, and Cryptococcus have
their natural habitats in the environment and in many instances
the infecting fungal organisms are acquired from the surrounding
environment. Recently the use of azole-based agricultural
chemicals has also been implicated as a major factor in the
increase in frequency of multiple-triazole-resistant (MTR) isolates
of A. fumigatus infecting humans by selection of MTR alleles
[24,25]. This is supported by a recent report originating from the
Netherlands that showed over 90% of Dutch azole resistant A.
fumigatus isolates recovered from epidemiologically unrelated
patients clustered onto a single lineage [13]. In the present study
7% of the Indian environmental A. fumigatus isolates were multi-
triazole resistant with a single resistant mechanism carrying the
TR34/L98H mutation in the cyp51A gene (Table 1). The resistant
isolates were recovered from soil samples of potted plants, paddy
fields and tea gardens where certain triazole fungicides (tebuco-
nazole, hexaconazole, and epoxiconazole) were extensively used.
Although, Europe leads the world in usage of agricultural
fungicides (40%) followed by Japan and Latin America, in India
usage of fungicides is increasing and current fungicide use in India
is 19% of the total pesticide use [26]. In the USA the use of azoles
in agriculture is insignificant as compared to Europe (http://ec.
europa.eu/food/fs/sc/ssc/out278_en.pdf). Consequently, there
has been no report of finding the TR34/L98H mutation in clinical
or environmental isolates in the USA. But this resistance type has
been found in the environment in Europe and now also in India. It
is noteworthy that so far no environmental survey of TR34/L98H
A. fumigatus isolates outside Europe has been reported. The
fungicides belonging to different chemical groups have been
registered in India only in the past two decades and these are being
used against diverse diseases in fruits, vegetables, plantation crops
and some field crops [26]. Triazole fungicides such as hexacona-
zole, propiconazole, triadimefon, and tricyclazole account for a
substantial fungicide market in India [26]. Overall, the highest
fungicide usage in India is on pome fruits (12.7%), followed by
potatoes (12.2%), rice (12%), tea (9.4%), coffee, chillies, grape-
vines, other fruits and vegetables [26]. Also, triazole fungicides are
characterized by their long persistence in soil. Singh and Dureja
demonstrated that hexaconazole persist longer in Indian soil due
to its hydrophobic nature [27]. In India, the maximum amounts of
fungicide usage are found in southern India, followed by western,
Table 2. In- vitro antifungal susceptibility profile of medical triazoles and triazole fungicides against environmental and clinical
Aspergillus fumigatus isolated in India.
MIC* (mg/L)
Triazole
drugs and
fungicides Environment Clinical Effect size r
TR34/L98H (n=44)
251676672Wild type
(n =22) TR34/L98H (n=9) Wild type (n =13)
GM* MIC50* Range GM MIC50 Range GM MIC50 Range GM MIC50 Range
Itraconazole 16 16 16–.16 0.43 0.5 0.25–1 16 16 16.16 0.11 0.125 0.03–1 0.96
Voriconazole 8.7 8 4–16 0.65 0.5 0.25–1 5.9 8 2–16 0.10 0.125 0.03–0.25 0.91
Posaconazole 1.03 1 0.5–2 0.46 0.5 0.06–1 3.2 2 1–.8 0.25 0.25 0.125–1 0.72
Bromuconazole 31.4 32 16–.32 2.5 2 1–4 32 32 32–.32 2.2 2 1–4 0.96
Cyproconazole 32 32 32–.32 30.9 32 16–.32 32 32 32–.32 29.4 32 16–32 0.22
Difenoconazole 31.4 32 16–.32 2.0 2 1–8 32 32 32–.32 1.8 2 0.5–4 0.96
Epoxiconazole 32 32 32–.32 5.2 4 2–16 32 32 32–.32 4.1 4 2–8 0.92
Hexaconazole 31 32 8–.32 4.87 4 2–8 32 32 .32 3.39 4 2–8 0.95
Metconazole 3.8 4 1–8 0.3 0.5 0.125–1 4 4 2–16 0.4 0.5 0.25–2 0.89
Penconazole 32 32 32–.32 30.9 32 32–.32 32 32 32–.32 32 32 32–.32 0
Tebuconazole 31.4 32 16–.32 2.6 2 1–8 32 32 .32 3.0 4 1–8 0.96
Triadimefon 32 32 .32 32 32 .32 32 32 .32 32 32 32–.32 0
Tricyclazole 32 32 32–.32 32 32 32–.32 32 32 .32 32 32 32–.32 0
*Minimum inhibitory concentration; GM, geometric mean.
doi:10.1371/journal.pone.0052871.t002
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eastern and northern Indian states. In this study the multi triazole
resistant A. fumigatus carrying the TR34/L98H genotype was
isolated from Union Territory (UT) of Delhi (northern region),
West Bengal and Bihar (eastern region of India about 1100 Km
from the North) and Tamil Nadu (southern region of India, about
2100 Km from the North) states. The western region of India has
yet to be surveyed but considering the high usage of fungicides in
this region, isolation of azole resistant A. fumigatus may be
anticipated.
Previous environmental surveys of azole resistant A. fumigatus
have only been reported from Europe (the Netherlands and
Denmark) and those surveys identified that 12% (6/49) of Dutch
soil samples and 8% (4/50) of Danish soil samples were positive for
the TR34/L98H genotype [15,17]. Only one other mutation in the
cyp51A gene combined with a different tandem repeat (TR46/
Y121F/T289A) that was putatively linked to an environmental
origin has been reported from clinical samples [28] and this
genotype constituted 36% of resistant isolates in a Dutch referral
centre [29]. The present study represents one of the largest
environmental surveys of multi-triazole resistant A. fumigatus done
so far and detected that 7% of the A. fumigatus isolates and 5% of
soil/aerial samples distributed across large areas of India carried
Figure 2. Genotypic relationship between the wild-type and TR34/L98H Aspergillus fumigatus (clinical and environmental isolates
from India, The Netherlands and France) and TR34/L98H A. fumigatus (clinical isolates from China and Germany). The dendrogram is
based on a categorical analysis of 9 microsatellite markers in combination with UPGMA clustering. The scale bar indicates the percentage identity.
Clinical: blue, Environmental: yellow, Resistant: red, Susceptible: green.
doi:10.1371/journal.pone.0052871.g002
Figure 3. Minimum spanning tree showing wide genotypic diversity in the TR34/L98H and wild type A. fumigatus isolates studied.
The figure shows the 74 different genotypes (circles), the number of strains belonging to the same genotype (sizes of the circles), and origin of
isolates (circles in yellow indicate Indian isolates; green Dutch isolates; red Chinese isolates; blue French isolates, purple German isolate and white
reference strain, AF293). Solid thick and thin branches indicates 1 or 2 microsatellite markers differences, respectively; dashed branches indicates 3
microsatellite markers difference between two genotypes; 4 or more microsatellite markers differences between genotypes are indicated with dotted
branches.
doi:10.1371/journal.pone.0052871.g003
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one single resistant mechanism. Culture of soil samples taken from
potted plants (where commercial compost was used) and kept
inside the hospital premises were positive for the same genotype.
In contrast, natural soil sampled from the gardens of Delhi and
hospitals did not grow the resistant A. fumigatus isolates although
they were positive for A. fumigatus. Our findings corroborate with
the findings of a Dutch environmental report where none of the A.
fumigatus isolates obtained from natural soil was found to be azole
resistant [15]. Therefore, environmental surveys for detection of
genotype TR34/L98H resistant A. fumigatus isolates may focus on
sampling of soil from fields and commercial compost where
fungicides are invariably used. It is noteworthy that the air samples
of patient’s wards of VPCI hospital harboured the same genotype
of multi-triazole resistant A. fumigatus, isolated on two different
occasions which raises concern on the exposure of hospitalized
patients to this resistant genotype. In this context it is pertinent to
mention that previously multi-triazole resistant TR34/L98H A.
fumigatus isolates have been reported from patients attending the
outpatient departments of VPCI who were never exposed to azoles
[22]. In addition multi-triazole resistant A. fumigatus has also been
isolated from admitted patients of VPCI. The presence of A.
fumigatus resistant to medical triazoles poses a threat to immuno-
compromised patients as alternative therapy is limited.
Snelders et al. reported that TR34/L98H isolates from clinical
and environmental origins were cross resistant to five triazole
DMIs fungicides, propiconazole, bromuconazole, tebuconazole,
epoxiconazole and difenoconazole and thus supporting the
hypothesis that exposure of A. fumigatus to azole fungicides in the
environment causes cross resistance to medical triazoles. [21].
Furthermore, these investigators also reported that these five
triazole DMIs showed very similar molecule structures to the
medical triazoles and adopted a similar conformation while
docking the target enzyme and exhibit activity against wild type
A. fumigatus but not against multi-triazole resistant TR34/L98H A.
fumigatus [21]. Similarly, in the present study four of the five
(bromuconazole, tebuconazole, epoxiconazole and difenocona-
zole) triazole DMIs known to have similar molecule structures as
medical triazoles showed significantly higher MICs for multi
triazole resistant TR34/L98H A. fumigatus from environmental and
clinical samples than those of wild type strains (Table 2). In
addition, metconazole and hexaconazole also showed high MICs
for multi-triazole resistant A. fumigatus isolates with the TR34/
L98H mutation. Attention is called to the report of Serfling et al.,
who used the maize anthracnose fungus Colletotrichum graminicola
model system to study the acquisition of azole resistance and
investigated whether isolates that were resistant to an agricultural
azole show cross-resistance to azoles and antifungal agents of other
chemical classes used in medicine [30]. Their in-vitro data
revealed that C. graminicola was able to efficiently adapt to medium
containing azoles, and strains adapted to tebuconazole were less
sensitive to all agricultural and medical azoles tested than the non-
adapted control strain. Likewise, azole cross-resistance was
observed for yeast isolates from the oropharynx of human
immunodeficiency virus-infected patients to agricultural azole
drugs and for those from environmental sources to medical azole
drugs [31].
It is remarkable that all of the environmental and clinical TR34/
L98H A. fumigatus isolates in India had the same microsatellite
genotype. Although the environmental isolates originated from
geographically diverse regions of northern, eastern and southern
parts of India were separated from each other by about 2000 Km,
they harboured an identical short tandem repeat (STR) pattern.
The possibility of contamination during handling of samples was
ruled out by processing of the samples by different laboratory
personnel in two different laboratories in India and the Nether-
lands. Furthermore, we had reported earlier that two clinical
TR34/L98H A. fumigatus isolates originating from two azole naive
patients, who were residents of Bihar and Delhi, shared the same
STR pattern [22]. Moreover, azole-resistant strains from the
environment of Bihar and Delhi also showed the same STR
pattern. Notably, genetic analysis of a collection of MTR isolates
showed that all isolates with the TR34/L98H allele were all
confined within a single clade and were less variable than
susceptible isolates [25], consistent with a single and recent origin
of the resistant genotype.
Our results are consistent with the hypothesis that the azole-
resistant A. fumigatus strains analyzed here from across India were
due to the clonal spread of a single genotype. The lack of a single
azole-susceptible strain from either clinical origin or the environ-
ment in India with the same genotype as the widespread azole-
resistant genotype it may be conceivable that the resistant
genotype was unlikely the result of a single mutation at the
cyp51A gene in a common azole-susceptible genotype in India. In
addition, our genotype analysis suggest that the azole-resistant
genotype in India was likely an extremely adaptive recombinant
progeny derived from a cross between an azole-resistant strain
migrated from outside of India and a native azole-susceptible
strain from within India, followed by mutation. The abundant
phylogenetic incompatibility found in each of the sub-samples as
well as in the whole sample (where 100% of the loci pairs were
phylogenetically incompatible, thus consistent with recombination)
supports sexual mating in natural populations of this species in
India. Our inferred mechanisms have been similarly suggested for
the emergence of many virulent strains of viral, bacterial and
protozoan pathogens [32,33]. Once the extremely fit A. fumigatus
genotype emerged in India, it could spread quickly by producing a
large number of airborne asexual spores in the environment.
These airborne spores can easily disperse to other geographic
areas by air current or anthropogenic means. The widespread
application of triazole fungicides in the environment in India in
the last two decades could have contributed to its spread by
reducing the azole-susceptible genotypes and selecting for this
azole-resistant genotype. Whether this resistant genotype has
spread to neighbouring countries remain to be determined.
Materials and Methods
Ethics Statement
All necessary permits were obtained for the described field
studies.
Collection of Environmental Samples
A total of 486 environmental samples including soil from
flowerbeds of nurseries, surrounding parks of hospitals, cotton
trees, tea gardens, paddy fields, soil containing bird excreta,
decayed wood of tree trunks and aerial samples of the indoor
environment of hospital wards from the Union Territory (UT) of
Delhi, Haryana, Himachal Pradesh, Uttrakhand, Bihar, West
Bengal, Sikkim, Meghalaya and Tamil Nadu States were
investigated during July 2011–April 2012. The distribution of
the investigated 486 samples was as follows: UT of Delhi (n = 266),
Haryana (n= 21), Himachal Pradesh (n = 4), Uttrakhand (n= 21),
Bihar (n = 33), West Bengal (n = 59), Sikkim (n= 6), Meghalaya
(n = 11) and Tamil Nadu (n= 65).
Soil and Aerial Sampling
About two gram of soil was suspended in 8 ml of 0.85% NaCl,
vortexed and allowed to settle for 30 seconds. Subsequently, the
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suspension was diluted 1:10 and 100 ml was plated in duplicates on
Sabouraud dextrose agar plates supplemented with 50 mg/L
chloramphenicol and incubated at 37uC for 48 h. One gram of
decayed wood was suspended in 10 ml of 0.85% NaCl and
allowed to settle after vortexing it for 1 min. Then, 100 ml of
suspension was plated in duplicates on SDA and incubated at
37uC for 48 h.
For the indoor aerial sampling of the hospital, duplicate SDA
plates were exposed for 1 h in the corners and centre of the
general outpatient and wards of the V. P. Chest Institute (VPCI),
Delhi, on two different occasions. Plates were incubated for 48 h
at 37uC.
Identification
In order to detect overall prevalence of A. fumigatus the samples
were initially inoculated on SDA plates and maximum of 3
colonies per plate were purified and identified by macro- and
microscopic characteristics and growth at 50uC which differenti-
ated A. fumigatus from A. lentulus. Samples found out to be negative
for A. fumigatus were again processed without dilution and
inoculated directly on SDA plates. All of the A. fumigatus isolates
were then subcultured on SDA plates supplemented with 4 mg/L
itraconazole and incubated at 37uC for 48 h. Identification of all
the A. fumigatus isolates that grew on 4 mg/L itraconazole
containing SDA plates (ITC+ isolates) were confirmed by
sequencing of the internal transcribed spacer region. In order to
rule out any cryptic species within Aspergillus section Fumigati,
molecular identification was performed by amplification of parts of
the b-tubulin gene and calmodulin gene [34,35].
Antifungal Susceptibility Testing
The in vitro activity of all the standard azole antifungals was
investigated using CLSI M38-A2 broth microdilution [36]. A total
of 53 itraconazole resistant A. fumigatus isolates (44 ITC+
environmental and 9 ITC+ clinical) were subjected to AFST.
Nine itraconazole resistant clinical isolates were cultured from
patients suspected of bronchopulmonary aspergillosis. Among the
9 ITC+ A. fumigatus clinical isolates two have been reported earlier
[22]. In addition, 35 itraconazole susceptible A. fumigatus isolates
comprising 22 randomly selected wild type environmental and 13
azole susceptible clinical A. fumigatus isolates cultured from patients
of suspected bronchopulmonary aspergillosis were included as
controls. The drugs tested included itraconazole (ITC, Lee
Pharma, Hyderabad, India, and Janssen Research Foundation,
Beerse, Belgium), voriconazole (VRC, Pfizer Central Research,
Sandwich, Kent, United Kingdom) and posaconazole (POS,
Schering-Plough, Kenilworth, NJ, USA, now Astellas). For the
broth microdilution test, RPMI 1640 medium with glutamine
without bicarbonate (Sigma-Aldrich, St Louis, MO, USA)
buffered to pH 7 with 0.165 M 3-N-morpholinepropanesulfonic
acid (Sigma) was used. Isolates were grown on potato dextrose
agar for 5 days at 28uC and the inoculum was adjusted to a final
density of 0.5–2.5 x 104 cfu/ml by measuring 0.09–0.13 OD at
540 nm using spectrophotometer. The final concentrations of the
drugs were 0.03 to 16 mg/L for itraconazole and voriconazole
and 0.015 to 8 mg/L for posaconazole. Drug-free and mould-free
controls were included and microtitre plates were incubated at
35uC for 48 h. CLSI recommended quality control strains, Candida
krusei, ATCC6258 and Candida parapsilosis, ATCC22019 and
reference strains Aspergillus fumigatus, ATCC204305 and Aspergillus
flavus, ATCC204304 were included. The MIC end points were
read visually which, for azoles were defined as the lowest
concentration at which there was 100% inhibition of growth
compared with the drug-free control wells. A. fumigatus isolates with
high itraconazole MICs were tested twice on different days. Azole
resistance was defined for itraconazole, .2 mg/L, voriconazole,
.2 mg/L, and posaconazole, .0.5 mg/L as proposed by Verweij
et al. [37].
Activity of Azole Fungicides
The commonly used ten azole fungicides registered under the
Insecticides Act, 1968 by the Indian Central Insecticide Board and
Registration Committee were tested for activity against resistant
and wild type environmental and clinical A. fumigatus Indian
isolates by microdilution method as described above. The azole
fungicides tested were bromuconazole, cyproconazole, difenoco-
nazole, epoxiconazole, penconazole, tebuconazole, triadimefon,
metconazole (kindly gifted by Dr. P. Verweij, Nijmegen, the
Netherlands) hexaconazole (Rallis India, Mumbai, India) and
tricyclazole (Cheminova India, Mumbai, India). The fungicides
were dissolved in dimethyl sulfoxide and concentration range used
was 0.06–32 mg/L.
Statistical Analysis
Point serial correlation was computed between MICs of wild
type and TR34/L98H A. fumigatus isolates of clinical and
environmental origin to determine the correlation coefficient
which is a measure of the effect size (r), where values of r = 0
indicate no correlation between MICs, r = 1 indicate positive
correlation and r =21 indicate negative correlation. In cases
where correlation MICs have similar values for all isolates,
correlation effect size was considered r = 0 [21].
Mixed Format Real-time PCR Assay to Detect Mutations
All of the ITC+ A. fumigatus isolates were subjected to a mixed-
format real-time PCR assay as described previously for detection
of TR34/L98H, TR46/Y121F/T289A, M220, G54 mutations
leading to triazole resistance in A. fumigatus [38].
Microsatellite Genotypic Analysis
Genotyping was performed with a panel of nine short tandem
repeats as described previously [39]. The genetic relatedness
between Indian environmental and clinical isolates was deter-
mined by using microsatellite typing. A total of 60 ITC+ A.
fumigatus isolates which included 51 environmental (44 isolated in
the Indian laboratory and 7 isolated from Indian soil samples
processed in the Netherlands laboratory) and 9 clinical isolates
were subjected to microsatellite typing. For phylogenetic analysis,
24 Dutch (15 clinical and 9 environmental), 8 clinical Chinese
[40], 3 clinical French [18] and one clinical German [19] isolates
of A. fumigatus containing the TR34/L98H genotype were tested
along with the Indian isolates. In addition, 35 (22 environmental
and 13 clinical) Indian, 12 environmental Dutch and 2 clinical
French A. fumigatus isolates without mutations and a reference
strain A. fumigatus AF293 were included in the analysis.
Genetic Analysis of Microsatellite Genotypes
The composite genotype for each of the 146 strains of A.
fumigatus was identified based on alleles at all nine microsatellite
loci. The genotype information was then used to identify genetic
relationships among strains. Gene diversity and genotype diversity
within individual samples and the relationships between samples
were estimated using the population genetic analyses program
GenAlEx 6.1 [41]. The relationships among alleles at different loci
were examined for evidence of recombination in natural
populations of this fungus, using the computer program Multilocus
2.0 (http://www.agapow.net/software/multilocus/) [42]. Results
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of these analyses were used to infer the potential source(s) of the
triazole-resistant clinical and environmental A. fumigatus strains in
India.
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